Brian Lian

President & CEO

Brian Lian (President & CEO) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Viking Therapeutics, Inc. (VKTX). The largest single filing was $7.7M of VKTX (233,409 sh across 4 lots, as filed), executed Jan 5.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 3 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$14.0M

shares × price, as filed

Last traded

Jul 29

Filed Jul 29

Median ADV $77.4M across their filed names

Open performance→

Volume by month

Buys $0 Sells $23.1M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 3 filings

Sector per market data · by filing · past 12 months

Most traded names

VKTX

Viking Therapeutics, Inc. VKTX · 0 buys · 5 sells 5 filings

Recent filings

VKTXSALE Viking Therapeutics, Inc. View filing → $4.9M
148,517 sh × $33.32
Exec Jul 29
Filed Jul 29 · 8:07 PM ET VKTXSALE Viking Therapeutics, Inc. View filing → $7.7M
233,409 sh across 4 lots
Exec Jan 5
Filed Jan 5 · 5:30 PM ET VKTXSALE Viking Therapeutics, Inc. View filing → $1.4M
38,989 sh × $35.01
Exec Oct 28 2025
Filed Oct 28 2025 · 5:30 PM ET VKTXSALE Viking Therapeutics, Inc. View filing → $748K
26,889 sh × $27.80
Exec Jul 3 2025
Filed Jul 3 2025 · 5:30 PM ET VKTXSALE Viking Therapeutics, Inc. View filing → $8.3M
194,490 sh across 2 lots
Exec Jan 6 2025
Filed Jan 6 2025 · 5:30 PM ET VKTXSALE Viking Therapeutics, Inc. View filing → $15.3M
215,930 sh across 2 lots
Exec Sep 20 2024
Filed Sep 20 2024 · 5:30 PM ET